Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: A survey of current 'next-step' practices

Journal of Clinical Psychiatry

Volumn 61, Issue 6, 2000, Pages 403-408

  Fredman, Steffany J ^b   Fava, Maurizio ^b   Kienke, Allison S ^b   White, Candace N ^b   Nierenberg, Andrew A ^b   Rosenbaum, Jerrold F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL PRACTICE; DEPRESSION; DRUG RESPONSE; HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RELAPSE; TREATMENT OUTCOME;

EID: 0033938763     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0602     Document Type: Article

References (15)

1. Steffens DC, Krishnan KR, Helms MJ. Are SSRIs better than TCAs? comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety 1997;6: 10-18
2. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;276:1301-1302
3. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Pyschiatr Clin North Am 1996;19:179-200
4. Fava M, Kaji J, Davidson K. Pharmacologic strategies for treatment-resistant major depression. In: Pollack MH, Otto MW, Rosenbaum JF, eds. Challenges in Clinical Practice: Pharmacologic and Psychosocial Strategies. New York, NY: Guilford Press; 1996:3-30
5. Crismon ML, Trivedi M, Pigott TA, et al. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry 1999;60: 142-156
6. Nierenberg AA. Treatment choice after one antidepressant fails: a survey of Northeastern psychiatrists. J Clin Psychiatry 1991;52:383-385
7. Shergill SS, Katona CLE. Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists. J Affect Disord 1997;43:19-25
8. Mischoulon D, Fava M, Rosenbaum JF. Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice. Harvard Rev Psychiatry 1999;6:322-326
9. Byrne S, Rothschild AJ. Psychiatrists' responses to failure of maintenance therapy with antidepressants. Psychiatr Serv 1997;48:835-837
10. Chaimowitz GA, Links PS, Padgett RW, et al. Treatment-resistant depression: a survey of practice habits of Canadian psychiatrists. Can J Psychiatry 1991;36:353-356
11. Fava M, Rosenbaum JF, McGrath PJ, et al. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 1994;151:1372-1374
12. Fava M, Rappe SM, Pava JA, et al. Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose. J Clin Psychiatry 1995;56:52-55
13. Fava M, Dunner DL, Griest JH, et al. An open-label study with mirtazapine in depressed patients who are SSRI treatment failures. In: New Research Program and Abstracts of the 152nd Annual Meeting of the American Psychiatric Association; May 19, 1999; Washington, DC. Abstract NR431:186
14. Nierenberg AA, Feighner JP, Rudolph R, et al. Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol 1994;14:419-423
15. Thase ME, Zajecka J, Kornstein SG, et al. Nefazodone treatment of patients with poor response to SSRIs. Presented at the 37th annual meeting of the American College of Neuropsychopharmacology (ACNP); Dec 14-18, 1998; Los Croabas, Puerto Rico